The 8-hour Buprenorphine Training - PART 1-The Half and Half Course Agenda

The Half and Half Course Agenda

Pdf Summary

The PCSS Half and Half Course is a training program that focuses on the office-based treatment for opioid use disorders. This course is divided into two parts, with Part 1 consisting of 4.25 hours of content. The course covers various topics related to the treatment of opioid use disorder using buprenorphine/naloxone. <br /><br />The overview section provides an introduction to the treatment with buprenorphine/naloxone and its effectiveness in managing opioid use disorder. The patient evaluation section focuses on the assessment process for patients seeking treatment for opioid use disorder. <br /><br />Specialty topics section covers specific areas related to the treatment, such as co-occurring disorders and treating special populations. The course includes case studies to illustrate the application of the treatment in real-life scenarios. <br /><br />The clinical uses of buprenorphine section discusses different clinical settings and populations in which buprenorphine can be used as a treatment option. The urine drug testing section explains the importance of monitoring patients' drug use and the role of urine drug testing in treatment. <br /><br />The overview of clinical tools section provides an overview of various tools and resources that can assist healthcare providers in the treatment of opioid use disorder. The course concludes with a Q&A session where participants can ask questions and clarify any doubts. <br /><br />Throughout the training, there will be interactive polling questions that randomly appear. Participants are not graded on these questions but are required to answer them for participation credit. These questions help assess participants' understanding of the material and ensure their engagement in the presentation and case studies. <br /><br />The funding for this initiative was made possible by a grant from SAMHSA, and the views expressed in the materials do not necessarily reflect the official policies of the Department of Health and Human Services. Mention of trade names, commercial practices, or organizations does not imply endorsement by the U.S. Government.

Keywords

PCSS Half and Half Course

office-based treatment

opioid use disorders

buprenorphine/naloxone

patient evaluation

co-occurring disorders

special populations

clinical uses of buprenorphine

urine drug testing

SAMHSA grant